Pilot COX-2 [cyclooxygenase-2] activity in early stage rectal cancer-short term administration of celecoxib (SPORE).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Celecoxib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 05 Mar 2013 Biomarkers information updated
- 09 Aug 2011 Planned end date changed from 1 Jan 2005 to 1 May 2005 as reported by ClinicalTrials.gov.
- 09 Aug 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.